GLP-1 Receptor Agonist Market

GLP-1 Receptor Agonist Market Size, Share, Growth Analysis, By Product Outlook(Victoza, Ozempic), By dureon(Saxenda, Others), By Regional Outlook(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35I2206 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

GLP-1 Receptor Agonist Market Insights

Market Overview:

In 2019, the market size of GLP-1 receptor agonists reached a significant valuation of USD 11.3 billion. Looking ahead, this market is expected to exhibit steady growth, with a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. GLP-1 receptor agonists are a class of medications used in the treatment of type 2 diabetes, and their increasing adoption and efficacy contribute to the positive market outlook. Factors such as rising prevalence of diabetes, growing awareness about the benefits of GLP-1 receptor agonists, and advancements in drug development are expected to drive market growth in the coming years. Overall, the GLP-1 receptor agonist market shows promising potential for expansion and innovation in the near future.

GLP-1 Receptor Agonist Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for GLP-1 Receptor Agonist was estimated to be valued at US$ XX Mn in 2021.

The GLP-1 Receptor Agonist Market is estimated to grow at a CAGR of XX% by 2028.

The GLP-1 Receptor Agonist Market is segmented on the basis of Product Outlook, dureon, Regional Outlook.

Based on region, the GLP-1 Receptor Agonist Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the GLP-1 Receptor Agonist Market are Eli Lilly and Company, Sanofi, Novo Nordisk A/S, AstraZeneca.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

GLP-1 Receptor Agonist Market

Product ID: UCMIG35I2206

$5,300
BUY NOW GET FREE SAMPLE